<DOC>
	<DOCNO>NCT02102711</DOCNO>
	<brief_summary>Vitamin A essential optimal growth , development . In newborn , especially preterm , necessary cellular differentiation , health anterior eye , constituent visual pigment , essential surfactant synthesis . Immune response Vitamin A supplementation demonstrate reduces infancy mortality , low ( &lt; 1500g birth weight ) extremely low ( &lt; 1000g birth weight ) preterm infant bear low body store vitamin A high risk vitamin A deficiency . Nevertheless , optimal vitamin A supplementation infant clearly define , despite evidence benefit early supplementation . Prematurity associate risk bronchopulmonary dysplasia ( BPD ) disease mark respiratory compromise associate high mortality severe long-term morbidity , well prematurity associate risk retinopathy , pathology may relate less rhodopsin quantity seem dependent vitamin A concentration . Vitamin A give enterally , intramuscularly , intravenously . Recently oral administration drop available result particularly convenient avoid pain associate repetitive intramuscular injection , discomfort parenteral administration . Studies vitamin A infant population suggest plasma retinol concentration &gt; 0.7 µM/L indicate vitamin A sufficiency , nevertheless preterm infant low concentration concentration &lt; 0.35 µM/L dangerous . Vitamin A deficiency level may constitute problem preterm newborn , result example , histological alteration respiratory epithelium lead chronic lung disease , retinopathy prematurity , patency ductus arteriosis , immune competence deficiency . The aim present study verify efficacy tolerability new oral administration vitamin A drop , 3000 IU/kg/die 4 week , infant &lt; 1500g weight birth , verify competence supplementation reach ideal blood concentration ( ≥0.7 µM/L ) relate blood achieve concentration vitamin A outcome typical pathology , BPD ROP .</brief_summary>
	<brief_title>Oral Vitamin A Supplementation Neonates With Birth Weight &lt; 1500 g</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Retinopathy Prematurity</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>parent sign informed consent low birth weight infant undergo ventilation least 24 hour Infants able receive adequate breast formula milk parent deny informed consent congenital malformation infant able receive breast formula milk</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Days</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>VITAMIN A</keyword>
	<keyword>BLOOD CONCENTRATION</keyword>
	<keyword>retinopathy prematurity</keyword>
</DOC>